Endometriosis affects 10% of women globally, causing tissue similar to uterine lining to grow elsewhere in the body. Recent research shows the condition triggers systemic immune dysfunction extending far beyond the pelvis.
Patients experience debilitating fatigue, cognitive difficulties, and widespread pain due to chronic inflammation. Immune cells become less effective at clearing lesions while producing higher levels of inflammatory proteins like IL-6 and IL-1β in the bloodstream.
A 2025 study of 330,000 patients found endometriosis patients had roughly twice the odds of developing autoimmune conditions including rheumatoid arthritis, lupus, and Hashimoto's disease within two years.
This systemic immune perspective could transform treatment approaches. Current therapies target reproductive systems, but immune-modulating treatments may offer more effective long-term relief. Understanding endometriosis as a multi-system inflammatory disorder validates patients' experiences of symptoms like brain fog and joint pain as legitimate biological consequences.